Bacteriostatic Water · 10 mLIDR 69.600RESEARCH PEPTIDE
Semaglutide 30 mg

Semaglutide 30 mg
Semaglutide is a modified GLP-1 analogue studied for GLP-1 receptor activation, glucose regulation and appetite-related signalling.
About this research category
Laboratory receptor signalling and pharmacokinetic research. Approved medicines do not validate this research material for human use.
Labels describe study topics - not proven benefits, personal-use guidance or product compatibility.
IDR 2.000.000
Line total: IDR 2.000.000
Available from local Bali stock
Eligible in-stock orders confirmed before 5 PM Bali time can receive same-day dispatch, subject to order confirmation and fulfilment arrangements.
Gojek delivery is arranged to your hotel, villa or other Bali destination. Confirm the address, receiving contact and handover window with the team in WhatsApp.
Check Bali delivery areas: Canggu, Seminyak, Ubud & wider Bali →For laboratory and scientific research only · not for human consumption.
Laboratory supplies
Need bacteriostatic water?
Add BAC water to your order if required by your laboratory protocol. Choose the size below; compatibility depends on your research requirements.
Compare bacteriostatic water in Bali: 3 mL & 10 mL →
Bacteriostatic Water · 10 mLIDR 69.600
Bacteriostatic Water · 3 mLIDR 40.000Optional add-on, not added automatically. BAC water does not count towards the peptide-vial discount threshold.
Explore more research materials
Other listings in this category - not a recommendation to combine products.
AOD-9604 · 10 mgIDR 2.530.000Research categoryLipid-metabolism research
BPC-157 · 10 mgIDR 1.140.600Research categoryCell-migration research- Product
- Semaglutide
- Strength
- 30 mg
- Category
- Research Peptides
- Format standard
- Identity and capacity clearly labelled
- Use
- Laboratory and scientific research only
- Price
- IDR 2.000.000
- Availability
- 9 in stock
Semaglutide 30 mg research material.
Semaglutide is a modified GLP-1 analogue studied for GLP-1 receptor activation, glucose regulation and appetite-related signalling.
Research context
Semaglutide is a modified GLP-1 analogue investigated in receptor activation and metabolic regulation. Laboratory and animal studies examine GLP-1 receptor signalling and peptide pharmacokinetics. Clinical findings from approved semaglutide medicines do not establish the safety, efficacy or suitability of this research material for human use.


